Skip to main content

Table 6 Predictors for combined death and recurrent stroke on Day 90 after ischemic stroke

From: Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke

Variables

Odds Ratio

95% CI

P-value

Univariate

   

   High-density lipoprotein

0.921

0.857 to 0.990

0.026

   EPO therapy

0.206

0.043 to 0.983

0.004

   Creatinine

3.250

1.045 to 10.109

0.042

Multiple Stepwise

   

   High-density lipoprotein

0.909

0.842 to 0.983

0.016

   EPO therapy

0.155

0.031 to 0.772

0.023

  1. CI, confidence interval; EPO, erythropoietin; MANE, major adverse neurological event.